Journal Article

Rare genetic variation in PTPRB is associated with central serous chorioretinopathy, varicose veins and glaucoma

Turunen, Joni A., Yzer, Suzanne, Sobrin, Lucia, Wang, Xin, Kaarniranta, Kai, Iyengar, Sudha K., Kim, Soo Hyun, Hauser, Blake M., Brinks, Joost, Anthony, Scott A., Gorman, Bryan R., Rossin, Elizabeth J., Rämö, Joel T., Weng, Lu-Chen, Gorin, Michael B., Peachey, Neal S., Nealon, Cari L., Daly, Mark J., Singhanetr, Panisa, Halladay, Christopher W., Choi, Seung Hoan, Roncone, David P., Palotie, Aarno, van Dijk, Elon HC, Jurgens, Sean J., Pyarajan, Saiju, Luo, Yuyang, Tieger, Marisa G., Boon, Camiel JF, Ellinor, Patrick T., Wu, Wen-Chih

2025

Overview

Central serous chorioretinopathy is an eye disease characterized by fluid buildup under the central retina whose etiology is not well understood. Abnormal choroidal veins in central serous chorioretinopathy patients have been shown to have similarities with varicose veins. To identify potential mechanisms, we analyzed genotype data from 1,477 patients and 455,449 controls in FinnGen. We identified an association for a low-frequency (allele frequency = 0.5%) missense variant (rs113791087) in PTPRB , the gene encoding vascular endothelial protein tyrosine phosphatase (odds ratio=2.85, P = 4.5 × 10 -9 ). This was confirmed in a meta-analysis of 2,452 patients and 865,767 controls from 4 studies (odds ratio=3.06, P = 7.4 × 10 -15 ). Rs113791087 was associated with a 56% higher prevalence of retinal abnormalities (35.3% vs 22.6%, P = 8.0 × 10 -4 ) in 708 UK Biobank participants and, surprisingly, with increased risk of varicose veins (odds ratio=1.31, P = 2.3 × 10 -11 ) and reduced risk of glaucoma (odds ratio=0.82, P = 6.9 × 10 -9 ). Predicted loss-of-function variants in PTPRB , though rare in number, were associated with central serous chorioretinopathy in All of Us (odds ratio=17.09, P = 0.018). These findings highlight the significance of vascular endothelial protein tyrosine phosphatase in diverse ocular and systemic veno-vascular diseases. Central serous chorioretinopathy is an eye disease whose etiology is not well known. Here, the authors performed genetic association studies and identified vascular endothelial protein tyrosine phosphatase (VE-PTP) as a likely regulator of the risk of central serous chorioretinopathy, as well as other eye and vascular diseases.

• Publisher: Nature Publishing Group UK,Nature Publishing Group,Nature Portfolio
• Subject: 45 / 45/43 / 631/208/205/2138 / 692/420/2489/144 / 692/699/3161 / 692/699/75/593 / Abnormalities / Adult / Aged / Case-Control Studies / Central Serous Chorioretinopathy - epidemiology / Central Serous Chorioretinopathy - genetics / Etiology / Eye / Eye diseases / Female / Gene Frequency / Genetic diversity / Genetic Predisposition to Disease / Genotype / Genotypes / Glaucoma / Glaucoma - genetics / Humanities and Social Sciences / Humans / Male / Middle Aged / multidisciplinary / Mutation, Missense / Phosphatase / Polymorphism, Single Nucleotide / Protein-tyrosine-phosphatase / Proteins / Receptor-Like Protein Tyrosine Phosphatases, Class 3 - genetics / Risk management / Science / Science (multidisciplinary) / Tyrosine / Varicose veins / Varicose Veins - genetics / Vascular diseases / Veins